153 related articles for article (PubMed ID: 36863257)
1. Fasting-mimicking diet synergizes with ferroptosis against quiescent, chemotherapy-resistant cells.
Liu X; Peng S; Tang G; Xu G; Xie Y; Shen D; Zhu M; Huang Y; Wang X; Yu H; Huang M; Luo Y
EBioMedicine; 2023 Apr; 90():104496. PubMed ID: 36863257
[TBL] [Abstract][Full Text] [Related]
2. The rational modulation of autophagy sensitizes colorectal cancer cells to 5-fluouracil and oxaliplatin.
Baldasso-Zanon A; Silva AO; Franco N; Picon RV; Lenz G; Lopez PLDC; Filippi-Chiela EC
J Cell Biochem; 2024 Feb; 125(2):e30517. PubMed ID: 38224178
[TBL] [Abstract][Full Text] [Related]
3. A pre-existing population of ZEB2
Francescangeli F; Contavalli P; De Angelis ML; Careccia S; Signore M; Haas TL; Salaris F; Baiocchi M; Boe A; Giuliani A; Tcheremenskaia O; Pagliuca A; Guardiola O; Minchiotti G; Colace L; Ciardi A; D'Andrea V; La Torre F; Medema J; De Maria R; Zeuner A
J Exp Clin Cancer Res; 2020 Jan; 39(1):2. PubMed ID: 31910865
[TBL] [Abstract][Full Text] [Related]
4. Glutathione Peroxidase 4 as a Therapeutic Target for Anti-Colorectal Cancer Drug-Tolerant Persister Cells.
Zhang X; Ma Y; Ma J; Yang L; Song Q; Wang H; Lv G
Front Oncol; 2022; 12():913669. PubMed ID: 35719967
[TBL] [Abstract][Full Text] [Related]
5. Andrographis-mediated chemosensitization through activation of ferroptosis and suppression of β-catenin/Wnt-signaling pathways in colorectal cancer.
Sharma P; Shimura T; Banwait JK; Goel A
Carcinogenesis; 2020 Oct; 41(10):1385-1394. PubMed ID: 32835374
[TBL] [Abstract][Full Text] [Related]
6. Reactivating p53 and Inducing Tumor Apoptosis (RITA) Enhances the Response of RITA-Sensitive Colorectal Cancer Cells to Chemotherapeutic Agents 5-Fluorouracil and Oxaliplatin.
Wiegering A; Matthes N; Mühling B; Koospal M; Quenzer A; Peter S; Germer CT; Linnebacher M; Otto C
Neoplasia; 2017 Apr; 19(4):301-309. PubMed ID: 28284059
[TBL] [Abstract][Full Text] [Related]
7. Dovitinib synergizes with oxaliplatin in suppressing cell proliferation and inducing apoptosis in colorectal cancer cells regardless of RAS-RAF mutation status.
Gaur S; Chen L; Ann V; Lin WC; Wang Y; Chang VH; Hsu NY; Shia HS; Yen Y
Mol Cancer; 2014 Feb; 13():21. PubMed ID: 24495750
[TBL] [Abstract][Full Text] [Related]
8. Low-dose orlistat promotes the therapeutic effect of oxaliplatin in colorectal cancer.
Zhang Q; Zhou Y; Feng X; Gao Y; Huang C; Yao X
Biomed Pharmacother; 2022 Sep; 153():113426. PubMed ID: 36017794
[TBL] [Abstract][Full Text] [Related]
9. LEF1 silencing sensitizes colorectal cancer cells to oxaliplatin, 5-FU, and irinotecan.
Fakhr E; Zare F; Azadmanesh K; Teimoori-Toolabi L
Biomed Pharmacother; 2021 Nov; 143():112091. PubMed ID: 34474344
[TBL] [Abstract][Full Text] [Related]
10. circHIPK3 promotes oxaliplatin-resistance in colorectal cancer through autophagy by sponging miR-637.
Zhang Y; Li C; Liu X; Wang Y; Zhao R; Yang Y; Zheng X; Zhang Y; Zhang X
EBioMedicine; 2019 Oct; 48():277-288. PubMed ID: 31631038
[TBL] [Abstract][Full Text] [Related]
11. [The efficacy and side effects of rigosertib combined with chemotherapy in
Zhang HC; Zhou XY; Fu DL; Ding YW; Xiao Q; Yuan Y
Zhonghua Zhong Liu Za Zhi; 2023 Feb; 45(2):138-145. PubMed ID: 36781234
[No Abstract] [Full Text] [Related]
12. Long-term resistance to 5-fluorouracil promotes epithelial-mesenchymal transition, apoptosis evasion, autophagy, and reduced proliferation rate in colon cancer cells.
Sousa-Squiavinato ACM; Arregui Ramos DA; Wagner MS; Tessmann JW; de-Freitas-Junior JCM; Morgado-Díaz JA
Eur J Pharmacol; 2022 Oct; 933():175253. PubMed ID: 36067803
[TBL] [Abstract][Full Text] [Related]
13. Colossolactone-G synergizes the anticancer properties of 5-fluorouracil and gemcitabine against colorectal cancer cells.
Algehani RA; Abou Khouzam R; Hegazy GA; Alamoudi AA; El-Halawany AM; El Dine RS; Ajabnoor GA; Al-Abbasi FA; Baghdadi MA; Elsayed I; Hattori M; Al-Abd AM
Biomed Pharmacother; 2021 Aug; 140():111730. PubMed ID: 34062410
[TBL] [Abstract][Full Text] [Related]
14. Prodigiosin impairs autophagosome-lysosome fusion that sensitizes colorectal cancer cells to 5-fluorouracil-induced cell death.
Zhao C; Qiu S; He J; Peng Y; Xu H; Feng Z; Huang H; Du Y; Zhou Y; Nie Y
Cancer Lett; 2020 Jul; 481():15-23. PubMed ID: 32184145
[TBL] [Abstract][Full Text] [Related]
15. Suppression MGP inhibits tumor proliferation and reverses oxaliplatin resistance in colorectal cancer.
Huang C; Wang M; Wang J; Wu D; Gao Y; Huang K; Yao X
Biochem Pharmacol; 2021 Jul; 189():114390. PubMed ID: 33359068
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of BIRC7/Livin, Bcl-2, p53, Annexin V, PD-L1, DARC, MSH2 and PMS2 in colorectal cancer treated with FOLFOX chemotherapy with or without aspirin.
Faruk M; Ibrahim S; Aminu SM; Adamu A; Abdullahi A; Suleiman AM; Rafindadi AH; Mohammed A; Iliyasu Y; Idoko J; Saidu R; Randawa AJ; Musa HS; Ntekim A; Shah KZ; Abubakar S; Adoke KU; Manko M; Awasum CA
PLoS One; 2021; 16(1):e0245581. PubMed ID: 33465114
[TBL] [Abstract][Full Text] [Related]
17. The c-Myc/miR-27b-3p/ATG10 regulatory axis regulates chemoresistance in colorectal cancer.
Sun W; Li J; Zhou L; Han J; Liu R; Zhang H; Ning T; Gao Z; Liu B; Chen X; Ba Y
Theranostics; 2020; 10(5):1981-1996. PubMed ID: 32104496
[TBL] [Abstract][Full Text] [Related]
18. Combinative treatment of β-elemene and cetuximab is sensitive to KRAS mutant colorectal cancer cells by inducing ferroptosis and inhibiting epithelial-mesenchymal transformation.
Chen P; Li X; Zhang R; Liu S; Xiang Y; Zhang M; Chen X; Pan T; Yan L; Feng J; Duan T; Wang D; Chen B; Jin T; Wang W; Chen L; Huang X; Zhang W; Sun Y; Li G; Kong L; Chen X; Li Y; Yang Z; Zhang Q; Zhuo L; Sui X; Xie T
Theranostics; 2020; 10(11):5107-5119. PubMed ID: 32308771
[No Abstract] [Full Text] [Related]
19. Synergistic efficacy of 3n-butyrate and 5-fluorouracil in human colorectal cancer xenografts via modulation of DNA synthesis.
Bras-Gonçalves RA; Pocard M; Formento JL; Poirson-Bichat F; De Pinieux G; Pandrea I; Arvelo F; Ronco G; Villa P; Coquelle A; Milano G; Lesuffleur T; Dutrillaux B; Poupon MF
Gastroenterology; 2001 Mar; 120(4):874-88. PubMed ID: 11231942
[TBL] [Abstract][Full Text] [Related]
20. FAM98A promotes resistance to 5-fluorouracil in colorectal cancer by suppressing ferroptosis.
He Z; Yang J; Sui C; Zhang P; Wang T; Mou T; Sun K; Wang Y; Xu Z; Li G; Deng H; Shi J; Zhuang B
Arch Biochem Biophys; 2022 Jun; 722():109216. PubMed ID: 35421356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
